Author: Kim, Jong Han; Kang, Hye Ree; Kim, Su Yeong; Ban, Ji-Eun
Title: Discrimination of Kawasaki disease with concomitant adenoviral detection differentiating from isolated adenoviral infection Document date: 2018_2_28
ID: wfq2ka4s_13
Snippet: All of the KD patients were initially treated with IVIG (2 g/kg) for 12 hours and additionally treated with IVIG in case of IVIG resistance. IVIG resistance was defined as a persistent or recrude scent fever for >48 hours after initial IVIG completion. In the case of recurrent or persistent fever with twice IVIG therapy, we managed with the fever with methylprednisolon pulse therapy or infliximab. After the acute phase, all patients have been giv.....
Document: All of the KD patients were initially treated with IVIG (2 g/kg) for 12 hours and additionally treated with IVIG in case of IVIG resistance. IVIG resistance was defined as a persistent or recrude scent fever for >48 hours after initial IVIG completion. In the case of recurrent or persistent fever with twice IVIG therapy, we managed with the fever with methylprednisolon pulse therapy or infliximab. After the acute phase, all patients have been given low dose aspirin for 8 weeks. Low dose aspirin was discontinued unless the coronary artery abnormalities persisted.
Search related documents:
Co phrase search for related documents- acute phase and coronary artery abnormality: 1
- acute phase and dose aspirin: 1, 2
- acute phase and IVIG resistance: 1
- acute phase and ivig therapy: 1, 2, 3
- acute phase and IVIG treat: 1
- acute phase and pulse therapy: 1, 2, 3, 4, 5
- artery abnormality and coronary artery abnormality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- dose aspirin and ivig therapy: 1, 2
- dose aspirin and low dose aspirin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53
Co phrase search for related documents, hyperlinks ordered by date